Metraipolis › archive › dc_34723e2bd78a

XYL-1 and Olaparib Synergistically Inhibit the Growth of Pancreatic Cancer by Suppressing the SCD1/BRCA1 Signaling Pathway — Europe PMC PMID:42653863

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42653863
DOI
10.3390/molecules31162781
License (as archived)
solo-consultazione
Archived
2026-10-16T21:50:50.401Z
SHA-256 of the archived text
3e3fd60fe628737b25c8f82e8cd46dbab9941f28d2cd61942303c2676b34a20e
Stable URL of this page
https://metraipolis.com/documento/dc_34723e2bd78a

How to cite

XYL-1 and Olaparib Synergistically Inhibit the Growth of Pancreatic Cancer by Suppressing the SCD1/BRCA1 Signaling Pathway — Europe PMC PMID:42653863 — Europe PMC (en), https://europepmc.org/article/MED/42653863 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_34723e2bd78a (Metraipolis archive dc_34723e2bd78a, sha256 3e3fd60fe628737b25c8f82e8cd46dbab9941f28d2cd61942303c2676b34a20e)
BibTeX
@misc{dc34723e2bd78a,
  title = {XYL-1 and Olaparib Synergistically Inhibit the Growth of Pancreatic Cancer by Suppressing the SCD1/BRCA1 Signaling Pathway — Europe PMC PMID:42653863},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42653863},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_34723e2bd78a; sha256 3e3fd60fe628737b25c8f82e8cd46dbab9941f28d2cd61942303c2676b34a20e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42653863. Agents can read the archived copy with the MCP tool read_document.